Consumer Advocacy

Consumer Advocacy


“What can I do?”


The Alberta government is reviewing the Alberta Tobacco and Smoking Reduction Act with the intent to include vaping products. The government is looking to stakeholders to provide information to help guide the decision-making process. If you are a resident in Alberta, you are a stakeholder in this conversation.


Contact MLA Jeremy Nixon
. He is the head of the review.

Legislative e-mail: Calgary.Klein@assembly.ab.ca
Facebook: www.facebook.com/JeremyNixon/


“What do I say?”


Introduce yourself: Include your name, provincial riding, postal code, and age.



Share your vaping story
: How old were you when you started smoking? What age did you start vaping?  Did you use vapour products to stop/reduce smoking? If you used vaping to reduce smoking, how much did it reduce your smoking? Are flavours important to you? How would you feel if flavours/vapour technology was no longer accessible? What do you think would happen to you personally if flavours/vapour technology were no longer accessible to you?



In your own words, just say what vaping is to you. Keep it simple, and don’t worry about including scientific data if you’re not comfortable doing so. The most important thing we can do is have our voices heard. Share our experiences and show the positive effect vaping has had on our lives.



If you decide to schedule a meeting with your MLA, be sure to come prepared and dress up in your Sunday best. Write down talking points beforehand so they are fresh in your memory. Share your experiences with vaping and how it has affected you. Leaving a positive impression on your MLA is very important.



Useful resources for advocacy:

  • Original Royal College of Physicians report on tobacco harm reduction
    Nicotine without smoke: Tobacco harm reduction

    The most commonly cited line of the report is in the conclusion to chapter 5 (page 87):

    "Although it is not possible to precisely quantify the long-term health risks associated with e-cigarettes, the available data suggest that they are unlikely to exceed 5% of those associated with smoked tobacco products, and may well be substantially lower than this figure"


  • New England Journal of Medicine article comparing vaping to nicotine-replacement therapy
    A Randomized Trial of E-Cigarettes versus Nicotine -Replacement Therapy

  • VAEP World, a useful collection of advocacy resources and info-graphics
    VAEPWorld

 

Leave a comment

Please note, comments must be approved before they are published